Annaida is a Swiss Healthtech company, who’s developed and patented a NMR technology, able to provide a fast, non-invasive and quantitative embryo screening, giving patients an improved overall IVF experience.

Gora Conley
CEO & co-founder

Marco Grisi
CTO & co-founder

• Infertility treatment
• Reproductive health

Open for investments for Series A.

Artidis is a Swiss Healthtech company, who’s developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization, with a platform that allows physicians to optimize diagnostics.

Marija Plodinec
CEO & Board Member, Co-Founder

Marko Loparic
CMO & Head of Digital Health, Co-Founder

Philipp Oertle
Head of Research & Development, Co-Founder

Tobias Appenzeller
Head of Quality & Clinical Operations, Co-Founder

Breast cancer

Open for investments for Series A.

Aspivix is a Swiss medical device startup, devoted to women’s healthcare. The company has created a substitute for the tenaculum, in order to improve the Gynecological experience.

Mathieu Horras
CEO & Co-Founder

David Finci
Co-Founder

Julien Finci
Co-Founder

IUD procedures

Open for investments for Series A.

BioReperia is a Swedish biotech company, based also in Switzerland, dedicated to provide services that accelerate anti-cancer drug discovery, assisting in selecting candidates efficiently and rapidly.

Lasse Jensen
Co-Founder

Bladder cancer

Open for investments for Series A.

Cellestia Biotech is a research and development company that develops innovative first-in-class therapies by selectively inhibiting transcription factors in the cell nucleus in multiple disease areas. Currently, their lead compound CB-103 is in Phase 2 of clinical trials and successfully treating cancer patients who are resistant to multi-drug treatments.

Rajwinder Lehal
CEO & Co-Founder

Solid Tumors and Leukemia

Currently not fundraising.

hemotune AG is a spin-off company originating out of the Functional Materials Lab at ETH Zurich. It has designed a multi-target precision medicine blood purification treatment to restore immune balance in septic shock and improve patient outcomes.

Carlos Mora
Co-Founder

Lukas Langenegger
Co-Founder

Sepsis

Currently not fundraising.

Hi-D imaging is a Swiss medtech startup. HI-D is developing a new technology, supported by AI, that aims to revolutionize the medical imaging sector by reducing pre-operational/surgical planning complexity.

Özge Karakaş
Co-Founder

Utku Gülan
Co-Founder

• Pre-operational surgery.
• Risk assessment for cardiac operations. 

Open for investments for Seed Series.

inQbator AG is a start-up accelerator that seeks the most promising innovative companies and help them grow through accelerator programs offering hands-on mentoring, specialized services and access to funding.

HEMEX, BLKB, Launchpad

Inura Medical is a Swiss biopharma company, developing the first-of-a-kind urethral ovulum to treat patients who suffer from overactive bladder (OAB).

Professor Grant S. Mulholland (†)
Founder

Vanja Ivancevic
CEO

Overactive bladder

Open for investments for Series A.

Resistell is a Swiss medtech startup, working on a solution for SEPSIS. They’ve patented a technology able to deliver AST diagnostic results in hours instead of days, allowing clinicians to halt sepsis by providing the right treatment to the patient on time.

Danuta Cichocka
CEO, Co-Founder

Giovanni Dietler
Inventor, Co-Founder

Sandor Kasas
Inventor, Co-Founder

Sepsis

Open for investments for Series B.

Scailyte is a Swiss biotech company, the startup, with a data driven approach, is working on a solution that provides unprecedented insight into diseases and enables ultra-sensitive diagnostics by uncovering human’s hidden “single-cell” secrets.

Peter Nestorov
Co-Founder & CEO

Manfred Claassen
Co-Founder

• Sezary Syndrome (CTCL)
• Endometriosis
• ARDS
• Non-small Cell Lung Cancer (NSCLC)
• DLBCL (CAR-T cells)

Open for investments for Series A.

Sleepiz is a Swiss medtech startup, working on a device that operates in a non-contact fashion and measures movements originating from heart contractions and breathing patterns, as well as body motions with medical grade accuracy.

Soumya Sunder Dash
Co-Founder & CEO

Max Sieghold
Co-Founder

Marc Rullan
Co-Founder & CTO

• Sleep Apnea
• Chronic respiratory diseases
• COVID-19

Currently not fundraising.

Tolremo is a Swiss biotechnology company. Based on cutting-edge science and guided by pioneering real-world medicine, the company created a broad cancer drug resistance platform that provides a unique entry point into a major clinical problem.

Stefanie Flückiger-Mangual
Co-Founder & CEO

Resistance preventing precision therapies to patients with cancer.

Fundraising Series A2.